首页 | 本学科首页   官方微博 | 高级检索  
     

不同通量血液透析联合血液透析滤过对胰岛素抵抗尿毒症患者的疗效比较
引用本文:黄炎驱,林延明,余丹红. 不同通量血液透析联合血液透析滤过对胰岛素抵抗尿毒症患者的疗效比较[J]. 中华肥胖与代谢病电子杂志, 2021, 7(1): 36-40. DOI: 10.3877/cma.j.issn.2095-9605.2021.01.007
作者姓名:黄炎驱  林延明  余丹红
作者单位:1. 529000 江门,江门市人民医院肾内科
基金项目:江门市医疗卫生领域科技计划项目(2019020100110001026)
摘    要:目的 对比不同通量血液透析联合血液透析滤过对胰岛素抵抗尿毒症患者的疗效.方法 选取江门市人民医院2019年5月至2020年8月60例胰岛素抵抗尿毒症患者作为研究对象,随机分为两组,每组30例,分别采用低通量血液透析联合血液透析滤过(LFHD+HDF)和高通量血液透析联合血液透析滤过(HFHD+HDF)干预,对比两组患者...

关 键 词:不同通量  血液透析  血液透析滤过  胰岛素抵抗  尿毒症
收稿时间:2020-10-26

Comparison of the curative effect of different flux hemodialysis combined with hemodiafiltration on patients with insulin resistance uremia
Yanqi Huang,Yanming Lin,Danhong Yu. Comparison of the curative effect of different flux hemodialysis combined with hemodiafiltration on patients with insulin resistance uremia[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2021, 7(1): 36-40. DOI: 10.3877/cma.j.issn.2095-9605.2021.01.007
Authors:Yanqi Huang  Yanming Lin  Danhong Yu
Affiliation:1. Department of Nephrology, Jiangmen People's Hospital, Jiangmen 529000, China
Abstract:ObjectiveTo compare the effects of different fluxes of hemodialysis combined with hemodiafiltration on insulin-resistant uremia patients. MethodsA total of 60 insulin-resistant uremia patients from Jiangmen People's Hospital from May 2019 to August 2020 were selected as the research subjects. They were randomly divided into two groups, 30 cases in each group, and they were treated with low-flux hemodialysis combined with hemodiafiltration. (LFHD+HDF) and high flux hemodialysis combined with hemodiafiltration (HFHD+HDF) intervention. The fasting blood glucose (FPG), fasting plasma insulin (FINS), insulin resistance index (HOMA-IR) before treatment and 3 months and 6 months after treatment were compared between the two groups, as well as their cholesterol (TC) and triacyl Glycerin (TG), serum albumin (ALB), blood urea nitrogen (BUN), creatinine (SCr), β2-microglobulin (β2-MG), parathyroid hormone (PTH), hypersensitive C-reactive protein (Hs) -CRP) and other related indicators. ResultsThe FINS and HOMA-IR levels of the HFHD+HDF group after 3 and 6 months of treatment were lower than those of the LFHD+HDF group (P<0.05). And the levels of TC, TG, PTH and Hs-CRP in the HFHD+HDF group after 3 and 6 months of treatment were significantly lower than those in the LFHD+HDF group, the difference was statistically significant (P<0.05); the HFHD+HDF group was The levels of TC, TG, PTH and Hs-CRP after 3 and 6 months of treatment were significantly lower than those of the LFHD+HDF group (P<0.05), and the Kt/V levels of the LFHD+HDF group were significantly lower than the treatment for 6 months Before, the Kt/V level of the HFHD+HDF group was significantly higher than that before treatment, and was significantly higher than that of the LFHD+HDF group, the difference was statistically significant (P<0.05). ConclusionsHigh-flux hemodialysis combined with hemodiafiltration (HFHD+HDF) compared with low-flux hemodialysis combined with hemodiafiltration (LFHD+HDF) can improve insulin resistance and body lipid metabolism in patients with insulin resistance uremia, and improve renal function.
Keywords:Different fluxes  Hemodialysis  Hemodiafiltration  Insulin resistance  Uremia  
点击此处可从《中华肥胖与代谢病电子杂志》浏览原始摘要信息
点击此处可从《中华肥胖与代谢病电子杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号